SYBLEU Inc

Pharmaceutical Preparations·BRONX, NY

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

SYBLEU Inc

Pharmaceutical Preparations·BRONX, NY

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$11,700

+188.7% YoY

FY 2023

Adj. EBITDA

—

Net Income

-$132,307

-1130.8% margin

FY 2023

EPS (Diluted)

—

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$0

FY 2021

Total Debt

$470,439

FY 2023

Net Debt

$470,439

FY 2023

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

Revenue

$11,700

+188.7% YoY

FY 2023

Adj. EBITDA

—

Net Income

-$132,307

-1130.8% margin

FY 2023

EPS (Diluted)

—

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$0

FY 2021

Total Debt

$470,439

FY 2023

Net Debt

$470,439

FY 2023

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—